One in Five UK Soctors use AI Chatbots

A survey led by researchers at Uppsala University in Sweden reveals that a significant proportion of UK general practitioners (GPs) are integrating generative AI tools, such as ChatGPT, into their clinical workflows. The results highlight the rapidly growing role of artificial intelligence in healthcare - a development that has the potential to revolutionise patient care but also raises significant ethical and safety concerns.

"While there is much talk about the hype of AI, our study suggests that the use of AI in healthcare is not just on the horizon - it's happening now. Doctors are deriving value from these tools. The medical community must act swiftly to address the ethical and practical challenges for patients that generative AI brings," says lead researcher Dr Charlotte Blease, Associate Professor at Uppsala University.

The study reveals that 20 per cent of GPs reported using generative AI tools in their practice, with ChatGPT being the most frequently used AI tool. Conducted with collaborators at Harvard Medical School, Boston, USA and the University of Basel, Switzerland, this is the most comprehensive examination of generative AI in clinical practice since the launch of ChatGPT in November 2022.

The study was conducted in February 2024 as part of a monthly omnibus survey and was designed to include GPs from across different regions of the UK. Researchers surveyed 1,006 GPs registered with Doctors.net.uk, the largest professional network for UK doctors.

The aim of the study was to measure the adoption of AI-powered chatbots by GPs across the UK and to understand how these tools are being used in clinical settings. With the advent of large language models (LLMs), there has been substantial interest in their potential to support medical professionals in tasks ranging from documentation to differential diagnosis.

Apart from revealing that 20 per cent of GPs used AI tools in their practice, the study also shows that among users, 29 per cent utilised these tools for generating documentation after patient appointments, while 28 per cent employed them to assist with differential diagnosis.

These findings suggest that AI chatbots are becoming valuable assets in medical practice, particularly in reducing administrative burdens and supporting clinical decision-making. However, the use of these tools is not without risks. The potential for AI to introduce errors ("hallucinations"), exacerbate biases, and compromise patient privacy is significant. As these tools continue to evolve, there is an urgent need for the healthcare industry to establish robust guidelines and training programmes to ensure their safe and effective use.

"This study underscores the growing reliance on AI tools by UK GPs, despite the lack of formal training and guidance and the potential risks involved. As the healthcare sector and regulatory authorities continue to grapple with these challenges, the need to train doctors to be 21st century physicians is more pressing than ever," Blease concludes.

Blease CR, Locher C, Gaab J, Hägglund M, Mandl KD.
Generative artificial intelligence in primary care: an online survey of UK general practitioners.
BMJ Health Care Inform. 2024 Sep 17;31(1):e101102. doi: 10.1136/bmjhci-2024-101102

Most Popular Now

Study Finds One-Year Change on CT Scans …

Researchers at National Jewish Health have shown that subtle increases in lung scarring, detected by an artificial intelligence-based tool on CT scans taken one year apart, are associated with disease...

New AI Tools Help Scientists Track How D…

Artificial intelligence (AI) can solve problems at remarkable speed, but it’s the people developing the algorithms who are truly driving discovery. At The University of Texas at Arlington, data scientists...

Yousif's Story with Sectra and The …

Embarking on healthcare technology career after leaving his home as a refugee during his teenage years, Yousif is passionate about making a difference. He reflects on an apprenticeship in which...

AI Tool Offers Deep Insight into the Imm…

Researchers explore the human immune system by looking at the active components, namely the various genes and cells involved. But there is a broad range of these, and observations necessarily...

New Antibiotic Targets IBD - and AI Pred…

Researchers at McMaster University and the Massachusetts Institute of Technology (MIT) have made two scientific breakthroughs at once: they not only discovered a brand-new antibiotic that targets inflammatory bowel diseases...

Highland to Help Companies Seize 'N…

Health tech growth partner Highland has today revealed its new identity - reflecting a sharper focus as it helps health tech companies to find market opportunities, convince target audiences, and...